unknown
Stage
1
Investors
About
Vitruviae develops proprietary immunotherapies targeting sugars and lipids uniquely expressed on cancer cells and cancer stem cells to improve efficacy and safety in cancer treatment, with a focus on acute myeloid leukemia and solid tumors.
Explore Vitruviae's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.